Ostarine is definitely the closest SARM to getting authorised in medicine and it is at this time in section II scientific trials. Like SARMs generally, MK-2866 targets androgen receptors on the selective basis and avoids producing the sorts of unsafe side effects involved with substances like testosterone, human growth hormone, https://matthewn654zqe1.wikirecognition.com/user